Navigation Links
Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene
Date:4/6/2011

IRVINE, Calif., April 6, 2011 /PRNewswire/ -- Life Extension, a global authority on nutrition, health, and wellness and a provider of dietary supplements, has launched a product featuring ChromaDex's (CDXC.OB) pTeroPure pterostilbene, which is now available in many local health food stores and natural retailers.

Life Extension pTeroPure contains 50 mg of pTeroPure pterostilbene, a compound naturally found in blueberries.  Pterostilbene has been shown to be superior to a similar compound, resveratrol, which occurs naturally in grapes and is commonly associated with the heart-healthy benefits of red wine.  Pterostilbene has a higher potential for cellular uptake due to its better absorption and longer half-life in the blood, properties that may provide enhanced physiological benefits.  

ChromaDex's pTeroPure pterostilbene is a 99%-plus pure pterostilbene that is superior to other stilbenes on the market due to its sustainable sourcing and ultra-high purity.  ChromaDex was recently presented with the Most Promising Ingredient of the Year award for pTeroPure by Frost & Sullivan, an independent research company.

"pTeroPure continues to make waves in the natural products industry and is an ingredient in more than 17 dietary supplements," remarks Jeremy Bartos, PhD, ChromaDex's pTeroPure Product Manager.  "This partnership with Life Extension adds to that growing list and is indicative of the rising demand for this promising ingredient across the industry.  We look forward to utilizing Life Extension's market expertise, reputation, and retail influence to increase the presence of pTeroPure in the consumer market."

This product is now available through domestic health and natural food stores and online at http://www.lef.org.

About Life Extension

Life Extension is a global nonprofit research foundation and an authority on nutrition, health and wellness. It provides scientific information on anti-aging and optimal health and produces nutraceuticals for the dietary supplements industry.

About ChromaDex

ChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an impressive pipeline of new ingredients, including its pTeroPure pterostilbene on which it has worldwide, exclusive patent rights.  ChromaDex is a publicly-traded life-sciences company (OTC Bulletin Board: CDXC)

ChromaDex Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements.  Actual results may differ materially from those projected or implied in any forward-looking statements.  Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company's Securities and Exchange Commission filings.  The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Life Extension Contact
Rey Searles, Director of Marketing
954-766-8433
rsearles@lef.org

ChromaDex Investor Inquiries:
Liviakis Financial Communications, Inc.
John M. Liviakis, President
415-389-4670
John@Liviakis.com

ChromaDex Contact
Jenny Robles
Administrative Assistant to the CEO and the President
10005 Muirlands Blvd, Suite G, Irvine, CA 92618
949-419-0288
jennyr@chromadex.com

Media Inquiries:
Carolyn Hawley
Canale Communications
619-849-5375
carolyn@canalecomm.com


'/>"/>
SOURCE ChromaDex
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Generex Launches New Corporate Website
2. Berg Diagnostics Launches Molecular Diagnostics Services and Products at American Association for Cancer Research (AACR) 102nd Annual Meeting
3. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
4. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
5. Medstreaming Launches Fully Integrated Cardiovascular PACS and Certified EMR With Electronic Whiteboard at ACC
6. ORFLO Launches First Hands-free Mini Automated Cell Counter
7. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
8. Online Forum for Accountable Care Organization Developments Launches Today; Squire Sanders Sponsorship Reflects Commitment to Leadership in Emerging Health Policy Debate
9. Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
10. Songbird® Hearing Launches the Worlds First High-Quality, Low-Cost Sound Enhancement Product Available at Retail
11. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):